[Remote] Associate Medical Director - Breast at Natera

Remote

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Devices, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

Clinical trial designRegulatory frameworksBiostatisticsBreast oncology treatment paradigmsClinical guidelinesDiagnostic workflowsLeadershipStakeholder engagement

Questions & Answers

Common questions about this position

Is this position remote?

The position is primarily remote, with potential for travel.

What is the salary for this role?

This information is not specified in the job description.

What are the key requirements for this position?

Candidates must have an M.D. and/or Ph.D., at least 5 years of post-fellowship clinical experience in breast oncology, minimum 3 years of clinical trial experience, and at least 2 years in Medical Affairs or Clinical Development roles in oncology.

What does the team structure look like for this role?

The role starts as an individual contributor with the potential to build and lead a team as the business scales.

What experience makes a strong candidate for this role?

A strong candidate will have deep knowledge of breast cancer treatment paradigms, clinical guidelines, diagnostic workflows, expertise in clinical trial design, regulatory frameworks, and biostatistics, along with a proven track record in oncology Medical Affairs or Clinical Development.

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free